These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 20119675)

  • 1. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
    Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
    Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
    Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
    Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
    Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
    Choi YS; Kim SH; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY
    Gynecol Obstet Invest; 2009; 67(2):73-80. PubMed ID: 18843190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor polymorphism and ischemic stroke: a case-control study in Chinese population.
    Cheng J; Liu J; Li X; Peng J; Han S; Zhang R; Xu Y; Nie S
    Acta Neurol Scand; 2008 Nov; 118(5):333-8. PubMed ID: 18477064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR; Shafiei N; Safarinejad S
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
    Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
    Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes.
    Hastie PM; Onagbesan OM; Haresign W
    Anim Reprod Sci; 2004 Aug; 84(1-2):93-105. PubMed ID: 15302390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
    Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
    Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
    J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
    Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma.
    Hsiao PC; Chen MK; Su SC; Ueng KC; Chen YC; Hsieh YH; Liu YF; Tsai HT; Yang SF
    J Surg Oncol; 2010 Aug; 102(2):163-9. PubMed ID: 20648588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the IGF axis in hepatocarcinogenesis.
    Scharf JG; Braulke T
    Horm Metab Res; 2003; 35(11-12):685-93. PubMed ID: 14710347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.